Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer

NCT04741204 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Limited staff to carry out study

Conditions

Breast Cancer Stage
Insulin Resistance
Racial Bias

Interventions

DRUG: Metformin Extended Release Oral Tablet

Sponsor

Woman's

Collaborators

[object Object]
[object Object]
[object Object]